Transverse arch stenting and its effect on systemic hypertension.
Ibrahim Halil DemirMurat Kardasİlker Kemal YücelRukiye İrem YekelerMustafa Orhan BulutEmine Hekim YılmazMurat SurucuSerdar EpcacanAhmet CelebiPublished in: Turk gogus kalp damar cerrahisi dergisi (2024)
Residual transverse arch lesions may contribute to the persistence of systemic hypertension after coarctation treatment. Transverse arch stent implantation can be performed safely with favorable outcomes, facilitating better blood pressure control. However, it should be noted that these patients remain at risk for lifelong hypertension and should be closely monitored in this regard.
Keyphrases
- blood pressure
- hypertensive patients
- end stage renal disease
- ejection fraction
- aortic dissection
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- arterial hypertension
- adipose tissue
- metabolic syndrome
- patient reported outcomes
- atrial fibrillation
- replacement therapy
- glycemic control
- combination therapy